Combination therapies using anti-pseudomonas psl and pcrv binding molecules

作者: Antonio Digiandomenico , Melissa Damschroder , Reena Varkey , Ralph Minter , Bret Sellman

DOI:

关键词:

摘要: This disclosure relates to combination therapies comprising anti-Pseudomonas Psl and PcrV binding molecules related compositions, for use in prevention treatment of Pseudomonas infection.

参考文章(106)
Craven De, Steger Ka, Nosocomial pneumonia in mechanically ventilated adult patients : Epidemiology and prevention in 1996 Seminars in Respiratory Infections. ,vol. 11, pp. 32- 53 ,(1996)
Mark Snavely, Robert Mabry, Therapeutic bispecific antibodies: The selection of stable single-chain fragments to overcome engineering obstacles. IDrugs : the investigational drugs journal. ,vol. 13, pp. 543- 549 ,(2010)
Christine J. Tkaczyk, Melissa Damschroder, Reena M. Varkey, Bret R. Sellman, Lei Hua, Jamese Johnson Hilliard, Li Peng, Vaheh Oganesyan, Partha Chowdhury, Antibodies that specifically bind Staphylococcus aureus alpha toxin and methods of use ,(2012)
Vaughn Smider, Helen Hongyuan Mao, Byeong Doo Song, James Graziano, Tyson Chase, Omar Bazirgan, Combinatorial antibody libraries and uses thereof ,(2009)
Wolfgang Fraunhofer, Nicholas William Warne, Ivan R.S. Correia, Angela Kantor, Czeslaw H. Radziejewski, Stable antibody compositions and methods for stabilizing same ,(2009)
Geoffrey T. Yarranton, Christopher R. Bebbington, Mark Baer, Kenneth Luehrsen, Antibodies to the pcrv antigen of pseudomonas aeruginosa ,(2008)
Helga Mikkelsen, Melissa Sivaneson, Alain Filloux, Key two‐component regulatory systems that control biofilm formation in Pseudomonas aeruginosa Environmental Microbiology. ,vol. 13, pp. 1666- 1681 ,(2011) , 10.1111/J.1462-2920.2011.02495.X